non-invasive telemetry what else but ecg ? pierre lainee claire grant – emily bailey
TRANSCRIPT
Non-invasive telemetryWhat else but ECG ?
Pierre Lainee
Claire Grant – Emily Bailey
Non invasive telemetry BP
Why would we use it in Tox studies ?
Because they give access to repeated dosing Because exposures are higher, potentially improving safety margins Because Phase 1 trials also include repeated administration Because small changes over long periods need attention If ECG is already collected with this method, limiting the need for
additional jacket training Because incidence of BP effects in preclinical studies is significant
2 EMKA Presentation– 21 September 2011
0%
20%
40%
60%
80%
100%
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
No Effect Effect at High Dose Effect at Mid Dose Effect at Low Dose
Impact of repeated dosing
Comparison of ECG findings beginning vs. end of studies
3 EMKA Presentation– 21 September 2011
Identical69%
Increase13%
Decrease18%
Different0%
Identical70%
Increase17%
Decrease13%
Different0%
Dog DRF studies (n=150) Dog 1-month studies (n=160)
Isn’t it likely to be similar for BP effects ?
Current Methods
4 EMKA Presentation– 21 September 2011
Blood Pressure
Invasive telemetry Not suitable for tox studies
Minimally invasive telemetry Growing interest and rational But still demanding and expensive
Invasive ear catheter Restraint/Stress 30s/twice a week
Respiration
Rodent WBPThis is an indirect measure of respiratory functionLimited in duration due to animal welfare constraints
Non-invasive Blood Pressure (NIBP)
5 EMKA Presentation– 21 September 2011
Utilises tail cuff Detects changes in oscillations Extended recording periods Freely moving animals Programmed to inflate/deflate every 4 min Cuff inflated to 240 mmHg Deflation takes ~ 30 s Reported as an average of 5 inflations (time point ±10 min) On average replace tail cuff ~ 1 per session From our experience, we feel that the difficulty of keeping the cuff on
is strongly related to the tail shape, e.g. some have very thick bases and the tail gets progressively thinner (cone- shaped)
Non-invasive Blood Pressure (NIBP)
• Tail is shaved (~ 10 cm)
• Animals are habituated to tail cuff (at the same time as jacket
training). First training session just jacket, second session
with tail cuff, third session with cuff inflating/deflating. Each
session gets progressively longer.
• Wrap the tail cuff round the tail, approximately 3 cm from the
base of the tail.
• Vetwrap is wrapped round the tail below the cuff to prevent the
cuff from slipping (a ‘stopper’).
• Another layer of vetwrap is placed round the cuff and the
‘stopper’.
• Do not wrap too tightly as this will impair blood flow. The tubes
coming out of the cuff are cut to correct length to and are
attached to the transmitter.
6 EMKA Presentation– 21 September 2011
Animal preparation
Respiratory Inductive Plethysmography (RIP)
RIP utilizes specialized belts containing inductive wires
placed around the thorax and abdomen.
Measures changes in inductance, which are
proportional to cross sectional area and then indirectly
to lung volume.
Enables calculation of breathing frequency (f), tidal
volume (TV) and minute volume (MV).
To get volume values, a face mask calibration is
required (approx. 30 sec measurement).
Good calibration performed pre-study and that
calibration coefficient used for subsequent recordings
for that dog.
Animal posture does not impact on calibration (let the
dog be in a relaxed position).
7 EMKA Presentation– 21 September 2011
Analysis
8 EMKA Presentation– 21 September 2011
Blood Pressure
Pulse amplitude vs. Cuff pressure plotted
SBP and DBP derived from curve
Respiration
Respiratory trace recording
Continuous acquisition and on-line analysis of ach breath(up to ~30,000 during a 24 hour recording)
Noisy data can easily be excluded
Analysis
Signals are acquired and analysed by the EMKA analysis system.
Methods
9 EMKA Presentation– 21 September 2011
4 reference compounds tested
Theophylline: 0, 5, 10 and 20 mg/kg
Clonidine: 0, 0.03, 0.1 and 0.3 mg/kg
Verapamil: 5, 10 and 15 mg/kg
L-NAME: 0 and 10 mg/kg
Single dose of vehicle followed by single dose of compound in ascending
concentrations at intervals of 2-5 days
Dogs are part of the invasive telemetry colony, naïve to jacket training
SBP, DBP and ECG recorded by invasive telemetry (INV)
SBP, DBP, ECG, f, TV, MV recorded by NIBP and RIP
Blood Samples taken at pre-dose, 1, 3 and 24 hours
All animals observed via CCTV for abnormal clinical signs and vomiting
NIBP vs. INV
10 EMKA Presentation– 21 September 2011
Values for both SBP (-14%) and DBP(-10%) are lower with the NIBP system than the INV.
NIBP system measures pressure in the medial coccygeal artery
INV measures pressure directly in the descending aorta
Reference (i.e. zero) value not undefined for INV
Sensitivity of NIBP systemTheophylline
11 EMKA Presentation– 21 September 2011Graphs only display high dose, mean ± SEM
• System detected increase in BP• Duration and magnitude similar to
invasive telemetry.
NIBP
INV
Sensitivity of NIBP system
L-NAME
12 EMKA Presentation– 21 September 2011
NIBP
INV
• System detected increase in BP• Duration and magnitude similar to
invasive telemetry.
Graphs only display high dose , mean ± SEM
Sensitivity of NIBP system
Clonidine
13 EMKA Presentation– 21 September 2011
• NIBP is less sensitive than INV for this decrease in BP
Graphs only display high dose , mean ± SEM
NIBP
INV
Verapamil
14 EMKA Presentation – 21 September 2011 Graphs only display high dose , mean ± SEM
• System detected decrease in BP• Duration and magnitude similar
to invasive telemetry• Effects on DBP are less marked
NIBP
INV
Sensitivity of NIBP system
NIBP variability
Using 4 animals the statistical power of NIBP and INV to detect significant changes in blood pressure are comparable.
Using the NIBP system with 4 dogs a change of 24 (SBP) and 18 (DBP) mmHg is significant (vs. 29 and 18 for INV)
Most of the difference in sensitivity comes from the ability to select the best periods with invasive telemetry (i.e. continuous vs. repeated timepoints)
15 EMKA Presentation – 21 September 2011
Baseline values(mmHg)
Significant Delta%(80% power, n=4)
Duration of recording
• Recording of NIBP has been limited to 6 h post-dose for welfare reasons and
better protection of the equipment.
• A review of AstraZeneca INV telemetry studies from 2000 (~300 studies) was
performed.
• 36 studies showed clear blood pressure related effects.
- T max ≤ 6h 35 studies
- Time of onset all below 4 h
- Return to baseline ≤ 6h 16 studies
• If recording for 6 h post-dose an effect would have been detected in all studies.
16 EMKA Presentation – 21 September 2011
Sensitivity of RIP system
17
5 mg/kg 10 mg/kg 20 mg/kg
BF +22% +18% +45%
TV +18% +21% +25%
MV +25% +41% +78%
0.03 mg/kg 0.01 mg/kg 0.3 mg/kg
BF -21% -16% -28%
Theophylline
Clonidine
EMKA Presentation – 21 September 2011
Graphs only display high dose
Sensitivity of RIP system
18 EMKA Presentation – 21 September 2011
10 mg/kg
BF +32%
TV -26%
MV -28%
L-NAME
Graphs only display high dose.% change is max effect compared to time matched vehicle.
NIBP Practical considerations
Pros and Cons
Although HDO offers a better outcome, it
seems that SBP effects are still better
detected than DBP ones Long term recording but not continuous,
which limits the selection of optimal period,
and secondarily decreases sensitivity Limitations in early studies due to small
groups Additional time for data analysis (but very
valuable data) Additional investment (but value for money)
Access to effects after repeated dosing with
no need for additional study and no surgery Easy to use with staff trained to external
telemetry Training is not a limitation as it takes place
along jacket training In a context where external telemetry is
used routinely, NIBP and RIP definitely add
value In the hands of a SP group, reference
compounds do show the expected effects Sensitivity can be compensated by larger
size groups in 1-month studies
19 EMKA Presentation – 21 September 2011
This validation work was convincingand NIBP will find a place in our CVS strategy
Testing Strategy
Include NIBP in repeat dose phase of dose range finding dog toxicology
study when blood pressure liability is identified from Project knowledge Earlier CVS studies (anesthetised GP or rat telemetry)
3Rs incentive of more data without increasing animal numbers
Include RIP in GLP invasive telemetry study (need more data first). Replace rodent whole body plethysmography study. 3Rs incentive of reduction of ~40 rodents per compound. Assess multiple organ systems simultaneously in large animals to explore the
pharmacological interaction in response to a drug.
20 EMKA Presentation – 21 September 2011
Conclusions
21 EMKA Presentation – 21 September 2011
10 minutes to jacket animal and perform 30 second calibration BP – 6 hours, Respiration and ECG 24 hours Detected changes in response to reference compounds Ease of analysis – eliminates noisy data No effect on quality of ECG measurements
Future Work and Perspectives
Now being used in repeat-dose tox studies Incorporation into ToE ?
Use of activity and video for clinical monitoring Improves vomiting detection
Possible replacement of WBP with RIP Bronchoconstriction – Carbachol
use of the shift between abdominal and thoracic signals)
Thanks
To all staff involved in testing over the last year
- Emily for her dedication along a placement year
- Claire for supervising the work and organising the
studies
- Jackie for helping with the invasive telemetry
acquisition and analysis
- Clare and Kate for bringing the expertise and patience
acquired from ECG recordings into this new method
To the EMKA team which provided
- the appropriate conditions and support for the required
adjustments to be made
- the training to facilitate data analysis optimisation
22 EMKA Presentation – 21 September 2011